Assertio Holdings announced that its Board of Directors has appointed Brendan O’Grady as the Company’s new Chief Executive Officer and a member of the board, effective today, May 29, 2024. Most recently, O’Grady was CEO of the Global Formulations business at Glenmark Pharmaceuticals, driving new product launches and focused on growing profitability in key markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASRT:
- Assertio Holdings initiated with a Buy at Alliance Global Partners
- Assertio to Participate in Benchmark Healthcare Conference on May 21-22
- Assertio Holdings holder Buxton Helmsley releases letter from fraud examiner
- Assertio to Participate in AGP Healthcare Conference on May 21
- Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
Questions or Comments about the article? Write to editor@tipranks.com